Coldstream Capital Management Inc Precigen, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 827 shares of PGEN stock, worth $1,257. This represents 0.0% of its overall portfolio holdings.
Number of Shares
827Holding current value
$1,257% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PGEN
# of Institutions
150Shares Held
161MCall Options Held
1.11MPut Options Held
36.8K-
Third Security, LLC83.5MShares$127 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.4MShares$26.4 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$17.1 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$15.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.8MShares$13.4 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $316M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...